Review Articles Concerning Pulmonary Vascular Disease

L-Citrulline: Novel Pharmacotherapy to Improve Outcomes in Infants and Children at Risk of Systemic or Pulmonary Vascular Disease

Candice D. Fike, Frederick E. Barr, Judy L. AschnerUniversity of Utah Health. Diversified Search Group. Hackensack Meridian School of Medicine.United States PharmaceuticalsPharmaceuticals 2026; 19: DOI: 10.3390/ph19060896 AbstractInfants and children suffering from a variety of heart, lung, and blood disorders are known to be at risk of developing systemic or pulmonary vascular disease. Despite progress made in

L-Citrulline: Novel Pharmacotherapy to Improve Outcomes in Infants and Children at Risk of Systemic or Pulmonary Vascular Disease Read More »

L-Citrulline in Maternal-Fetal and Neonatal Health: Metabolic Mechanisms and Emerging Therapeutic Applications

Ana Collins-Smith, Sangeeta Jain, Sunil JainUniversity of Texas Medical Branch at Galveston.United States NutrientsNutrients 2026; 18: DOI: 10.3390/nu18121923 AbstractL-citrulline is a non-protein amino acid with critical roles in perinatal and neonatal physiology through the intestinal-renal arginine-citrulline axis and nitric oxide (NO) production. During pregnancy, L-citrulline supports placental angiogenesis, vascular adaptation, and fetal growth through augmentation of

L-Citrulline in Maternal-Fetal and Neonatal Health: Metabolic Mechanisms and Emerging Therapeutic Applications Read More »

Congenital chylothorax in infants: An updated scoping review

A. Alghobaishi, S. I. Albraim, H. I. Albraim, N. S. Gubari, S. Khan, H. I. Thalib, S. AlaghaKing Fahad Armed Forces Hospital. Saudi German Hospital. MyClinic. Batterjee Medical College. Saudi Arabia African Journal of Thoracic and Critical Care MedicineAfr J Thorac Crit Care Med 2026; 32: DOI: 10.7196/AJTCCM.2025.v32i1.2701 AbstractBackground: Chylothorax is a medical condition characterised by the

Congenital chylothorax in infants: An updated scoping review Read More »

Bronchopulmonary dysplasia associated pulmonary hypertension: implications across the lifespan

Taylor P. Saley, Natalie Villafranco, Megan Griffiths, Kara N. GossUniversity of Texas at Austin Dell Medical School. Baylor College of Medicine and Texas Children’s Hospital. University of Texas Southwestern Medical Center. United States Paediatric Respiratory ReviewsPaediatr Respir Rev 2026; DOI: 10.1016/j.prrv.2026.05.006 AbstractBronchopulmonary dysplasia is a frequent complication of preterm birth and is often associated with the

Bronchopulmonary dysplasia associated pulmonary hypertension: implications across the lifespan Read More »

Recent Advances in Pulmonary Hypertension Management

Sarah P. Cohen Alexandria L. Miller, Saurabh Rajpal, Scott H. VisovattiOhio State University School of Medicine and Nationwide Children’s Hospital. United States Heart Failure ClinicsHeart Fail Clin 2026; 22: 371-385DOI: 10.1016/j.hfc.2026.02.011 AbstractSignificant progress has been made in the management of pulmonary hypertension (PH), and especially pulmonary arterial hypertnesion (PAH), over the last 3 decades. Recent advances

Recent Advances in Pulmonary Hypertension Management Read More »

The Role of Machine Learning and Artificial Intelligence in Drug Discovery and Clinical Care of Pulmonary Hypertension

Evelyne Bischof, Chaim Haber, Niklas LidströmerShanghai University of Medicine and Health Sciences. Sheba Medical Center, Grey School of Medicine and Tel Aviv University. University of Copenhagen. Karolinska Institutet. China, Israel, Denmark and Sweden Heart Failure ClinicsHeart Fail Clin 2026; 22: 361-370DOI: 10.1016/j.hfc.2026.02.009 AbstractPulmonary hypertension (PH) is a severe and oftentimes fatal disease with a high degree

The Role of Machine Learning and Artificial Intelligence in Drug Discovery and Clinical Care of Pulmonary Hypertension Read More »

Pediatric Pulmonary Infarction and Infarction-Like Pulmonary Injury: An Etiology-Oriented Narrative Review

Shuxuan Li, Yanran Zhang, Xiangxiang Tian, Wanqing Zhao, Yongsheng XuTianjin Medical University and Tianjin Children’s Hospital (Children’s Hospital of Tianjin University).China Seminars in Thrombosis and HemostasisSemin Thromb Hemost 2026; DOI: 10.1055/a-2889-7005 Abstract Pulmonary infarction (PI) has traditionally been regarded as a complication of pulmonary embolism (PE). However, increasing evidence suggests that pediatric PI represents a heterogeneous

Pediatric Pulmonary Infarction and Infarction-Like Pulmonary Injury: An Etiology-Oriented Narrative Review Read More »

Phenotyping bronchopulmonary dysplasia using magnetic resonance imaging

Samal Munidasa, Paul S. Kingma, Jason C. Woods, James A. RoweCincinnati Children’s Hospital and University of Cincinnati College of Medicine.United States Paediatric Respiratory ReviewsPaediatr Respir Rev 2026; DOI: 10.1016/j.prrv.2026.06.003 AbstractBronchopulmonary dysplasia (BPD) is characterized by impaired lung development and persistent respiratory morbidity. BPD comprises three primary phenotypes: parenchymal, airway, and pulmonary vascular disease. Parenchymal disease involves

Phenotyping bronchopulmonary dysplasia using magnetic resonance imaging Read More »

Contemporary Endothelial Genome Editing Technologies: Towards Precision Genetic Medicine for Vascular Diseases

You-Yang Zhou, Colin E. EvansAnn and Robert H. Lurie Children’s Hospital of Chicago and Northwestern University Feinberg School of Medicine. United States International Journal of Molecular SciencesInt J Mol Sci 2026; 27: DOI: 10.3390/ijms27115100 AbstractEndothelial dysfunction is a key characteristic of many diseases, including atherosclerosis, hypertension, heart failure, stroke, cancer, acute respiratory distress syndrome (ARDS), peripheral

Contemporary Endothelial Genome Editing Technologies: Towards Precision Genetic Medicine for Vascular Diseases Read More »

Evaluation and Management of Genetic Respiratory Disorders Presenting as Hypoxemic Respiratory Failure in the Newborn Infant

Jennifer A. Wambach, F. Sessions Cole, Lawrence M. NogeeWashington University School of Medicine and St. Louis Children’s Hospital. Johns Hopkins University. United States Clinics in PerinatologyClin Perinatol 2026; 53: 381-401DOI: 10.1016/j.clp.2026.03.003 AbstractHypoxemic respiratory failure is a common reason for admission to the neonatal intensive care unit for term and late preterm infants. Some infants have rare

Evaluation and Management of Genetic Respiratory Disorders Presenting as Hypoxemic Respiratory Failure in the Newborn Infant Read More »

Scroll to Top